Skip Navigation

Cardiovascular Research 2001 50(3):432-433; doi:10.1016/S0008-6363(01)00300-5
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Levi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levi, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

CMV endothelitis as a factor in the pathogenesis of atherosclerosis

Marcel Levi

Department of Internal Medicine and Vascular, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands

The first 10% of the full text of this article appears below.

See article by Guetta et al. [8] (pages 538–546) in this issue.

Although many factors that contribute to the development of atherosclerosis are known, major parts of its etiology need still to be elucidated. Since the 1970's a link between infectious disease and atherosclerotic disease has been hypothesized [1–3]. Infectious agents that are implicated in the pathogenesis of atherosclerosis include bacterial pathogens, such as Helicobacter pylori or Chlamydia pneumoniae, but also viruses are thought to play an important role [4]. Cytomegalovirus (CMV) is one of the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
M. Michaelis, T. A. T. Ha, H. W. Doerr, and J. Cinatl Jr
Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells
Cardiovasc Res, February 1, 2008; 77(3): 544 - 550.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Weis, T. N. Kledal, K. Y. Lin, S. N. Panchal, S. Z. Gao, H. A. Valantine, E. S. Mocarski, and J. P. Cooke
Cytomegalovirus Infection Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine in Transplant Arteriosclerosis
Circulation, February 3, 2004; 109(4): 500 - 505.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. Potena, G. Frascaroli, F. Grigioni, T. Lazzarotto, G. Magnani, L. Tomasi, F. Coccolo, L. Gabrielli, C. Magelli, M. P. Landini, et al.
Hydroxymethyl-Glutaryl Coenzyme A Reductase Inhibition Limits Cytomegalovirus Infection in Human Endothelial Cells
Circulation, February 3, 2004; 109(4): 532 - 536.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. L. Nerheim, J. L. Meier, M. A. Vasef, W.-G. Li, L. Hu, J. B. Rice, D. Gavrila, W. E. Richenbacher, and N. L. Weintraub
Enhanced Cytomegalovirus Infection in Atherosclerotic Human Blood Vessels
Am. J. Pathol., February 1, 2004; 164(2): 589 - 600.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
M. Kronschnabl and T. Stamminger
Synergistic induction of intercellular adhesion molecule-1 by the human cytomegalovirus transactivators IE2p86 and pp71 is mediated via an Sp1-binding site
J. Gen. Virol., January 1, 2003; 84(1): 61 - 73.
[Abstract] [Full Text] [PDF]